Treatment-related risk factors for hospital mortality in Candida bloodstream infections*
- 1 November 2008
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 36 (11), 2967-2972
- https://doi.org/10.1097/ccm.0b013e31818b3477
Abstract
To examine the relationship between treatment-related variables for Candida bloodstream infection and hospital mortality. Retrospective cohort analysis. Thousand two hundred-bed academic medical center. A total of 245 consecutive patients with Candida bloodstream infections who received antifungal therapy. Identification of treatment-related risk factors: central vein catheter retention, inadequate initial fluconazole dosing, and delayed administration of antifungal therapy. A total of 245 patients with Candida bloodstream infections who received antifungal therapy were identified. One hundred eleven (45.3%) patients were managed in an intensive care unit and analyzed as a separate subgroup. In the hospital cohort, 72 (29.4%) patients died during hospitalization and 40 (36.0%) patients died in the intensive care unit cohort. In the hospital cohort, logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (1-point increments) (adjusted odds ratio [AOR], 1.18; 95% confidence interval [CI], 1.11-1.25; p = 0.003), corticosteroid use at the time a positive blood culture was drawn (AOR, 3.41; 95% CI, 1.96-5.93; p = 0.027), inadequate initial fluconazole dosing (AOR, 3.31; 95% CI, 1.83-6.00; p = 0.044), and retention of a central vein catheter (AOR, 4.85; 95% CI, 2.54-9.29; p = 0.015) as independent determinants of hospital mortality. In the intensive care unit cohort, logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (1-point increments) (AOR, 1.21; 95% CI, 1.14-1.29; p = 0.001), inadequate initial fluconazole dosing (AOR, 9.22; 95% CI, 2.15-19.79; p = 0.004), and retention of a central vein catheter (AOR, 6.21; 95% CI, 3.02-12.77; p = 0.011), as independent determinants of hospital mortality. For both cohorts the incremental presence of treatment-related risk factors was statistically associated with greater hospital mortality. Treatment-related factors, including retention of central vein catheters and inadequate initial fluconazole dosing, were associated with increased hospital mortality in patients with Candida bloodstream infections. These data suggest that optimization of initial antifungal therapy and removal of central vein catheters may improve the outcomes of patients with Candida bloodstream infections.Keywords
This publication has 22 references indexed in Scilit:
- Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional StudyClinical Infectious Diseases, 2006
- Attributable mortality of candidemia: a systematic review of matched cohort and case-control studiesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital MortalityAntimicrobial Agents and Chemotherapy, 2005
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*Critical Care Medicine, 2003
- Attributable Mortality of Nosocomial Candidemia, RevisitedClinical Infectious Diseases, 2003
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- The Influence of Mini-BAL Cultures on Patient OutcomesChest, 1998
- APACHE IICritical Care Medicine, 1985